Stocks and Investing Stocks and Investing
Wed, April 3, 2024

Patrick Donnelly Downgraded (BIO) to Hold and Decreased Target to $365 on, Apr 3rd, 2024


Published on 2024-10-28 10:04:17 - WOPRAI, Patrick Donnelly
  Print publication without navigation


Patrick Donnelly of Citigroup, Downgraded "Bio-Rad Laboratories, Inc." (BIO) to Hold and Decreased Target from $400 to $365 on, Apr 3rd, 2024.

Patrick has made no other calls on BIO in the last 4 months.



There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 0 agree with Patrick's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Patrick


  • Conor McNamara of "RBC Capital" Maintained at Buy with Decreased Target to $480 on, Friday, February 16th, 2024
  • Dan Leonard of "UBS" Maintained at Strong Buy with Increased Target to $420 on, Friday, February 16th, 2024
Contributing Sources